by Eric Christianson | Nov 9, 2016 | Medication and Disease State Clinical Pearls For Pharmacists, Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls, Psychiatry and Addiction Medication and Disease State Clinical Pearls
Urine drug screens are often confusing if you don’t interpret them on a regular basis. I think a big reason for confusion is a lack of education on what these tools can do and what they look at. I would definitely classify myself as needing to learn more about...
by Eric Christianson | Oct 19, 2016 | Medication and Disease State Clinical Pearls For Pharmacists, Pharmacogenomics and Pharmacokinetics Medication and Disease State Clinical Pearls
In a previous post, I dug a little into pharmacodynamics. In this post I am going to be explaining pharmacokinetics. In pharmacy and the medical profession we tend to use really big, fancy words to intimidate people, not sure why, but we do. Remember that:...
by Eric Christianson | Oct 9, 2016 | Medication and Disease State Clinical Pearls For Pharmacists, Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls, Renal, Urology, and Electrolytes Medication and Disease State Clinical Pearls
I appreciate the fantastic guest post from Amanuel Tseggai, Pharm.D., BCPS! There are plenty of clinical considerations when it comes to gabapentin. Here’s a scenario of using gabapentin in chronic kidney disease. A 42 year old African American man with a history of...
by Eric Christianson | Oct 5, 2016 | Medication and Disease State Clinical Pearls For Pharmacists, Pharmacogenomics and Pharmacokinetics Medication and Disease State Clinical Pearls
Two very common terms in pharmacology and the pharmacy world in general are pharmacodynamics and pharmacokinetics. The best way I have been taught these terms is by the following: Pharmacodynamics – what the drug does to the body Pharmacokinetics – what...
by Eric Christianson | Sep 25, 2016 | Cardiovascular Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
There’s a lot that goes into selecting beta blocking agents. In pharmacy school we’ve learned that beta blockers fall into two major categories with respect to their pharmacotherapeutic properties: Selective (B1) and nonselective (B1,B2) beta antagonists....
by Eric Christianson | Sep 21, 2016 | Medication and Disease State Clinical Pearls For Pharmacists, Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls, Psychiatry and Addiction Medication and Disease State Clinical Pearls
KL is a 79 year old male with a history of Parkinson’s disease. About 2 weeks ago, he had been having worsening symptoms of rigidity and his wife is concerned with this newer development. At that time, his Sinemet dosing was increased from 25/100 TID to 50/200 TID....
